{"nct_id":"NCT01971281","title":"Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA)","status":"UNKNOWN","status_verified_date":"2017-09","start_date":"2013-11","start_date_type":null,"primary_completion_date":"2017-12","primary_completion_date_type":"ESTIMATED","completion_date":"2017-12","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["NVCR"]}